Geneos Wealth Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$117K Buy
1,324
+138
+12% +$11.8K ﹤0.01% 1305
2026
Q2
$91.5K Buy
1,186
+73
+7% +$5.32K ﹤0.01% 1241
2026
Q1
$72.7K Hold
1,113
– – ﹤0.01% 1289
2025
Q4
$88.2K Sell
1,113
-41
-4% -$3.14K ﹤0.01% 1184
2025
Q3
$84.2K Sell
1,154
-185
-14% -$13.6K ﹤0.01% 1178
2025
Q2
$102K Buy
1,339
+38
+3% +$2.69K ﹤0.01% 1246
2025
Q1
$98.9K Buy
1,301
+428
+49% +$31.9K ﹤0.01% 1169
2024
Q4
$57.7K Buy
+873
New +$61.1K ﹤0.01% 1263

Other funds holding SOLV

Geneos Wealth Management's SOLV Position: Q3 2026 in Review

Geneos Wealth Management increased its Solventum (SOLV) stake by 12% in Q3 2026, buying an estimated $11.8K and bringing the position to 1,324 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Geneos Wealth Management first reported a position in SOLV in Q4 2024 and has held it in 8 quarters since. 895 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Geneos Wealth Management held 1,324 shares of Solventum worth $117K as of Q3 2026.
  • Geneos Wealth Management bought 138 Solventum shares in Q3 2026, an estimated $11.8K.
  • Solventum made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1305 holding.
  • Geneos Wealth Management first reported a position in Solventum in Q4 2024 and has held it in 8 quarters since.
  • 895 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.